Pangaea
Meet Pangaea at the UK Pavilion (Hall B, Stand 2348).
Pangaea is a South San Francisco and London based provider of a novel AI-driven product for characterizing patients across 4,000 hard-to-diagnose conditions in a privacy-preserving and scalable manner, which is helping clinicians in the pharmaceutical and healthcare industry. Pangaea has clinically proven to discover 22x more undiagnosed, misdiagnosed and miscoded patients along with new insights; halve treatment costs; and drive sustainable collaborations between healthcare and the pharmaceutical industry. The founders (Dr. Vibhor Gupta, Prof. Yike Guo) have attracted $200 million through research and are advised by Lord David Prior (former Chairman of NHS England), Mr. Andy Palmer (former Head of Systems Integration at Novartis) and Dr. Thomas Dyrberg (former Managing Partner, Novo Holdings). Pangaea was awarded top tier status by Microsoft, which is exclusive for 30 of the 30,000 companies they work with and has provided the opportunity to apply its product across 140,000 healthcare providers globally.
